Welgene Biotech Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	168.29	224.33	173.5	188.13	158.59	199.77
Short-Term Investments	33	43	53	9	59	21
Trading Asset Securities	-	-	-	-	-	2.72
Cash & Short-Term Investments	201.29	267.33	226.5	197.13	217.59	223.49
Cash Growth	-14.05%	18.03%	14.90%	-9.40%	-2.64%	23.24%
Accounts Receivable	40.75	46.7	45.58	46.98	46.57	82.86
Other Receivables	0.41	1.4	3.61	3.24	0.75	4.28
Receivables	41.16	48.09	49.19	50.23	47.31	87.14
Inventory	53.61	39.08	36.88	53.77	33.98	26.99
Prepaid Expenses	4.58	4.63	5.96	4.45	2.46	2.74
Other Current Assets	6.27	4.69	5.32	0.71	0.86	0.77
Total Current Assets	306.9	363.83	323.84	306.28	302.2	341.13
Property, Plant & Equipment	309.31	234.45	174.88	198.82	78.63	30.67
Long-Term Investments	17.45	17.61	26.12	33.98	42.09	41.36
Other Intangible Assets	16.27	0.65	0.16	0.39	0.73	1.07
Long-Term Deferred Tax Assets	0.58	0.51	0.44	0.56	0.49	0.69
Other Long-Term Assets	8.09	5.15	2.8	8.13	11.57	9.62
Total Assets	658.59	622.19	528.25	548.16	435.71	424.54
Accounts Payable	26.95	25.17	16.91	17.37	18.99	12.53
Accrued Expenses	-	25.43	24.28	21.18	25.02	26.61
Short-Term Debt	15	12	9	11	11.21	12.56
Current Portion of Long-Term Debt	-	28.04	11.68	11.05	-	-
Current Portion of Leases	14.74	14.55	13.58	13.33	13.08	11.28
Current Income Taxes Payable	-	-	0.36	-	2.44	-
Current Unearned Revenue	45.63	54.2	56.13	46.18	29.45	46.53
Other Current Liabilities	58.18	5.02	4.66	7.84	4.51	4.71
Total Current Liabilities	160.51	164.4	136.59	127.94	104.71	114.22
Long-Term Debt	197.28	141.19	95.58	105.4	-	-
Long-Term Leases	22.84	30.25	-	13.58	26.9	-
Pension & Post-Retirement Benefits	-	-	-	-	0.12	0.24
Long-Term Deferred Tax Liabilities	0.26	0.26	0.32	0.3	0.03	0.02
Other Long-Term Liabilities	0.08	0.02	0.02	0.68	-	-
Total Liabilities	380.96	336.12	232.5	247.89	131.76	114.47
Common Stock	233.04	233.04	233.04	233.04	233.04	233.04
Additional Paid-In Capital	50.93	50.93	50.86	50.86	50.86	50.86
Retained Earnings	13.3	21.29	20.62	19.51	27.18	28.88
Comprehensive Income & Other	-24.14	-23.97	-16.61	-11.38	-7.32	-2.92
Total Common Equity	273.14	281.3	287.91	292.03	303.76	309.86
Minority Interest	4.49	4.78	7.84	8.24	0.2	0.21
Shareholders' Equity	277.63	286.07	295.75	300.27	303.95	310.06
Total Liabilities & Equity	658.59	622.19	528.25	548.16	435.71	424.54
Total Debt	249.85	226.03	129.83	154.35	51.19	23.84
Net Cash (Debt)	-48.56	41.31	96.66	42.78	166.4	199.64
Net Cash Growth	-	-57.27%	125.94%	-74.29%	-16.65%	31.38%
Net Cash Per Share	-2.05	1.77	4.15	1.84	7.13	8.64
Filing Date Shares Outstanding	24.47	23.3	23.3	23.3	23.3	23.3
Total Common Shares Outstanding	24.47	23.3	23.3	23.3	23.3	23.3
Working Capital	146.39	199.43	187.25	178.34	197.49	226.92
Book Value Per Share	11.16	12.07	12.35	12.53	13.03	13.30
Tangible Book Value	256.87	280.65	287.75	291.64	303.03	308.79
Tangible Book Value Per Share	10.50	12.04	12.35	12.51	13.00	13.25
Land	-	22.76	22.76	22.76	-	-
Buildings	-	97.7	97.7	97.7	-	-
Machinery	-	126.84	93.49	107.46	77.2	55.9